| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Cell Surface | 30 | 2006 | 862 | 2.760 |
Why?
|
| Urokinase-Type Plasminogen Activator | 24 | 2011 | 136 | 2.340 |
Why?
|
| Promoter Regions, Genetic | 36 | 2011 | 3101 | 1.670 |
Why?
|
| Matrix Metalloproteinase 9 | 16 | 2011 | 360 | 1.510 |
Why?
|
| Gene Expression Regulation, Enzymologic | 12 | 2007 | 703 | 1.470 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 30 | 2011 | 107 | 1.330 |
Why?
|
| Colonic Neoplasms | 12 | 2011 | 1390 | 1.160 |
Why?
|
| Transcription Factors | 18 | 2013 | 5270 | 1.060 |
Why?
|
| Accidents, Aviation | 2 | 2016 | 7 | 1.060 |
Why?
|
| Transcription Factor AP-1 | 12 | 2011 | 246 | 0.960 |
Why?
|
| Collagenases | 8 | 1998 | 74 | 0.800 |
Why?
|
| Transcription, Genetic | 13 | 2013 | 3154 | 0.790 |
Why?
|
| Transcriptional Activation | 15 | 2011 | 1070 | 0.760 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 5 | 1998 | 206 | 0.700 |
Why?
|
| Tumor Cells, Cultured | 39 | 2011 | 5395 | 0.670 |
Why?
|
| Transfection | 19 | 2013 | 2944 | 0.580 |
Why?
|
| Chromatin | 7 | 2006 | 942 | 0.570 |
Why?
|
| Neoplasm Invasiveness | 23 | 2010 | 3981 | 0.570 |
Why?
|
| Activating Transcription Factor 3 | 5 | 2010 | 31 | 0.560 |
Why?
|
| Mitogen-Activated Protein Kinases | 9 | 2004 | 639 | 0.550 |
Why?
|
| Aircraft | 1 | 2016 | 28 | 0.550 |
Why?
|
| Air Ambulances | 1 | 2016 | 28 | 0.550 |
Why?
|
| Gene Expression Regulation | 8 | 2013 | 4053 | 0.540 |
Why?
|
| NF-kappa B | 6 | 2004 | 1549 | 0.520 |
Why?
|
| Plasminogen Activators | 5 | 2003 | 52 | 0.520 |
Why?
|
| Sp1 Transcription Factor | 4 | 2005 | 188 | 0.510 |
Why?
|
| Military Personnel | 3 | 2013 | 225 | 0.500 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 5 | 2011 | 371 | 0.500 |
Why?
|
| Tetradecanoylphorbol Acetate | 7 | 2004 | 226 | 0.490 |
Why?
|
| Histones | 4 | 2011 | 1466 | 0.480 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 4 | 2006 | 220 | 0.450 |
Why?
|
| Gene Expression Regulation, Neoplastic | 15 | 2008 | 8873 | 0.440 |
Why?
|
| Prostatic Neoplasms | 6 | 2013 | 5767 | 0.390 |
Why?
|
| Lysosomes | 1 | 2013 | 347 | 0.370 |
Why?
|
| Genes, Reporter | 10 | 2007 | 798 | 0.360 |
Why?
|
| Chloride Channels | 1 | 2010 | 60 | 0.360 |
Why?
|
| MAP Kinase Signaling System | 2 | 2011 | 848 | 0.350 |
Why?
|
| Genes, ras | 4 | 2011 | 667 | 0.350 |
Why?
|
| Population Surveillance | 1 | 2013 | 627 | 0.340 |
Why?
|
| Gene Expression | 5 | 2006 | 3570 | 0.340 |
Why?
|
| Integrin beta4 | 1 | 2008 | 22 | 0.340 |
Why?
|
| Prostate-Specific Antigen | 1 | 2013 | 993 | 0.340 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2011 | 467 | 0.330 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2010 | 3552 | 0.320 |
Why?
|
| Peptide Fragments | 2 | 2004 | 1271 | 0.310 |
Why?
|
| DNA-Binding Proteins | 6 | 2004 | 4821 | 0.300 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2004 | 1538 | 0.300 |
Why?
|
| Prostate | 1 | 2013 | 1088 | 0.300 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 2 | 2007 | 57 | 0.300 |
Why?
|
| Curcumin | 2 | 2005 | 117 | 0.300 |
Why?
|
| Cell Movement | 5 | 2010 | 2466 | 0.290 |
Why?
|
| Glucuronidase | 2 | 2004 | 48 | 0.290 |
Why?
|
| Epigenesis, Genetic | 2 | 2011 | 1399 | 0.290 |
Why?
|
| Autophagy | 1 | 2013 | 927 | 0.280 |
Why?
|
| Matrix Metalloproteinases | 1 | 2007 | 143 | 0.280 |
Why?
|
| Binding Sites | 8 | 2011 | 2171 | 0.280 |
Why?
|
| Recombination, Genetic | 3 | 2007 | 613 | 0.270 |
Why?
|
| Base Sequence | 11 | 2008 | 4917 | 0.270 |
Why?
|
| Humans | 73 | 2021 | 261506 | 0.250 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 1258 | 0.250 |
Why?
|
| Matrix Metalloproteinase 2 | 3 | 2002 | 256 | 0.250 |
Why?
|
| DNA Primers | 5 | 2008 | 1399 | 0.250 |
Why?
|
| Transgenes | 1 | 2006 | 557 | 0.250 |
Why?
|
| Mutagens | 1 | 2005 | 187 | 0.240 |
Why?
|
| Flavonoids | 4 | 1998 | 188 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-jun | 5 | 2007 | 166 | 0.240 |
Why?
|
| Cell Nucleus | 6 | 2006 | 1620 | 0.240 |
Why?
|
| Daunorubicin | 1 | 2005 | 301 | 0.240 |
Why?
|
| Carcinoma, Squamous Cell | 7 | 1998 | 5437 | 0.230 |
Why?
|
| Trans-Activators | 3 | 2005 | 1555 | 0.230 |
Why?
|
| Cell Line | 10 | 2010 | 5114 | 0.230 |
Why?
|
| Proteins | 2 | 2002 | 1963 | 0.230 |
Why?
|
| Microfilament Proteins | 1 | 2006 | 487 | 0.230 |
Why?
|
| Colon | 2 | 2004 | 670 | 0.230 |
Why?
|
| Peptides, Cyclic | 1 | 2004 | 139 | 0.230 |
Why?
|
| Laminin | 6 | 2004 | 194 | 0.220 |
Why?
|
| DNA, Complementary | 5 | 2011 | 869 | 0.220 |
Why?
|
| Fibroblasts | 5 | 2006 | 1682 | 0.210 |
Why?
|
| Muscle Proteins | 1 | 2006 | 549 | 0.210 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 1533 | 0.210 |
Why?
|
| Blotting, Northern | 8 | 2004 | 682 | 0.210 |
Why?
|
| Up-Regulation | 7 | 2011 | 2450 | 0.210 |
Why?
|
| src-Family Kinases | 2 | 2004 | 478 | 0.200 |
Why?
|
| Neoplasm Metastasis | 5 | 2010 | 5112 | 0.200 |
Why?
|
| DNA Footprinting | 4 | 2006 | 34 | 0.200 |
Why?
|
| I-kappa B Proteins | 2 | 2004 | 170 | 0.200 |
Why?
|
| DNA Damage | 3 | 2010 | 1954 | 0.200 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2005 | 726 | 0.200 |
Why?
|
| Green Fluorescent Proteins | 3 | 2011 | 694 | 0.190 |
Why?
|
| Cloning, Molecular | 4 | 2010 | 1213 | 0.190 |
Why?
|
| RNA, Messenger | 14 | 2005 | 6150 | 0.190 |
Why?
|
| Interferons | 1 | 2002 | 291 | 0.190 |
Why?
|
| Molecular Sequence Data | 10 | 2004 | 6089 | 0.190 |
Why?
|
| Protein Binding | 8 | 2006 | 3438 | 0.190 |
Why?
|
| Enzyme Induction | 5 | 2004 | 249 | 0.190 |
Why?
|
| Mouth Neoplasms | 3 | 1998 | 713 | 0.180 |
Why?
|
| Dexmedetomidine | 1 | 2021 | 85 | 0.180 |
Why?
|
| 5' Untranslated Regions | 1 | 2000 | 93 | 0.180 |
Why?
|
| Acetylation | 3 | 2006 | 508 | 0.180 |
Why?
|
| Enzyme Inhibitors | 6 | 2004 | 1879 | 0.180 |
Why?
|
| Protein-Tyrosine Kinases | 5 | 2002 | 1756 | 0.180 |
Why?
|
| Hypnotics and Sedatives | 1 | 2021 | 218 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-raf | 6 | 2001 | 80 | 0.170 |
Why?
|
| Colorectal Neoplasms | 3 | 2008 | 3578 | 0.170 |
Why?
|
| Mice | 18 | 2010 | 34495 | 0.170 |
Why?
|
| Signal Transduction | 10 | 2013 | 11965 | 0.170 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 5 | 2004 | 301 | 0.160 |
Why?
|
| Zinc Fingers | 3 | 2010 | 205 | 0.160 |
Why?
|
| Blotting, Western | 8 | 2004 | 3536 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 7 | 2004 | 259 | 0.150 |
Why?
|
| Phosphoproteins | 2 | 2004 | 1152 | 0.150 |
Why?
|
| Apoptosis | 5 | 2006 | 7591 | 0.150 |
Why?
|
| Neoplasm Transplantation | 4 | 2010 | 1519 | 0.150 |
Why?
|
| Epithelial Cells | 2 | 2004 | 1818 | 0.150 |
Why?
|
| Repressor Proteins | 2 | 2002 | 1664 | 0.150 |
Why?
|
| Animals | 20 | 2010 | 59536 | 0.150 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2011 | 460 | 0.150 |
Why?
|
| United States | 5 | 2016 | 15433 | 0.150 |
Why?
|
| Amino Acid Sequence | 5 | 2008 | 4233 | 0.150 |
Why?
|
| Perioperative Care | 1 | 2021 | 451 | 0.150 |
Why?
|
| Cell Line, Tumor | 8 | 2011 | 14551 | 0.140 |
Why?
|
| Plasmids | 4 | 2007 | 837 | 0.140 |
Why?
|
| Disease Progression | 4 | 2010 | 6682 | 0.140 |
Why?
|
| Adenocarcinoma | 4 | 2010 | 7789 | 0.140 |
Why?
|
| Precipitin Tests | 3 | 2004 | 329 | 0.140 |
Why?
|
| Enzyme Activation | 4 | 2006 | 1764 | 0.140 |
Why?
|
| Alternative Splicing | 2 | 2011 | 584 | 0.130 |
Why?
|
| Protein Structure, Tertiary | 4 | 2006 | 1487 | 0.130 |
Why?
|
| Protein Kinases | 2 | 1998 | 874 | 0.130 |
Why?
|
| Injury Severity Score | 1 | 2016 | 237 | 0.130 |
Why?
|
| Deoxyribonuclease I | 2 | 2006 | 67 | 0.130 |
Why?
|
| Biomarkers, Tumor | 2 | 2013 | 10331 | 0.130 |
Why?
|
| Head and Neck Neoplasms | 4 | 2005 | 3976 | 0.130 |
Why?
|
| Aviation | 1 | 2014 | 10 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2010 | 507 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2008 | 3639 | 0.120 |
Why?
|
| Genes, erbB-2 | 1 | 1995 | 229 | 0.120 |
Why?
|
| Mice, Nude | 5 | 2010 | 4307 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2005 | 2488 | 0.120 |
Why?
|
| Models, Genetic | 4 | 2007 | 1113 | 0.120 |
Why?
|
| Extracellular Matrix | 4 | 1999 | 554 | 0.120 |
Why?
|
| Binding, Competitive | 2 | 2005 | 300 | 0.120 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 4 | 2001 | 118 | 0.120 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2013 | 15 | 0.110 |
Why?
|
| Lymphatic Metastasis | 1 | 2003 | 4844 | 0.110 |
Why?
|
| Luciferases | 3 | 2007 | 445 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2006 | 611 | 0.110 |
Why?
|
| Naphthalenes | 1 | 1993 | 83 | 0.110 |
Why?
|
| Molecular Weight | 4 | 2001 | 629 | 0.110 |
Why?
|
| Cell Shape | 1 | 2013 | 128 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 5159 | 0.110 |
Why?
|
| MAP Kinase Kinase 1 | 3 | 1998 | 160 | 0.110 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2005 | 323 | 0.110 |
Why?
|
| Imidazoles | 1 | 1998 | 999 | 0.110 |
Why?
|
| Antineoplastic Agents | 3 | 2005 | 14289 | 0.100 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 1237 | 0.100 |
Why?
|
| Cells, Cultured | 3 | 2010 | 5637 | 0.100 |
Why?
|
| Pyrimidines | 1 | 2004 | 3518 | 0.100 |
Why?
|
| Glycolipids | 1 | 2011 | 58 | 0.100 |
Why?
|
| Age Distribution | 1 | 2013 | 698 | 0.100 |
Why?
|
| RNA, Small Interfering | 2 | 2008 | 2216 | 0.100 |
Why?
|
| Basement Membrane | 3 | 2004 | 138 | 0.100 |
Why?
|
| Pyridines | 1 | 1998 | 1244 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 246 | 0.100 |
Why?
|
| Cellular Senescence | 1 | 2013 | 382 | 0.090 |
Why?
|
| RNA Interference | 2 | 2013 | 1408 | 0.090 |
Why?
|
| Plasminogen Inactivators | 1 | 1990 | 9 | 0.090 |
Why?
|
| src Homology Domains | 2 | 2002 | 124 | 0.090 |
Why?
|
| Proteoglycans | 4 | 2004 | 259 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2013 | 534 | 0.090 |
Why?
|
| HeLa Cells | 1 | 2013 | 1643 | 0.090 |
Why?
|
| HCT116 Cells | 1 | 2010 | 348 | 0.090 |
Why?
|
| Models, Biological | 3 | 2008 | 3254 | 0.080 |
Why?
|
| Cell Division | 4 | 2006 | 2489 | 0.080 |
Why?
|
| Genetic Vectors | 2 | 2005 | 1694 | 0.080 |
Why?
|
| Drug Combinations | 4 | 2004 | 621 | 0.080 |
Why?
|
| Flow Cytometry | 2 | 2006 | 3033 | 0.080 |
Why?
|
| Genes, jun | 3 | 2001 | 41 | 0.080 |
Why?
|
| Metalloendopeptidases | 3 | 1999 | 170 | 0.080 |
Why?
|
| Glioma | 4 | 2002 | 1963 | 0.080 |
Why?
|
| Neoplasm Grading | 1 | 2013 | 1742 | 0.080 |
Why?
|
| Cyclohexylamines | 1 | 1987 | 16 | 0.080 |
Why?
|
| Time Factors | 4 | 2013 | 12926 | 0.080 |
Why?
|
| Eflornithine | 1 | 1987 | 59 | 0.080 |
Why?
|
| Ubiquitination | 1 | 2010 | 575 | 0.080 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 1082 | 0.080 |
Why?
|
| Neoplasm Proteins | 2 | 1996 | 3230 | 0.080 |
Why?
|
| Collagen | 4 | 2004 | 752 | 0.080 |
Why?
|
| Polyamines | 1 | 1987 | 75 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2005 | 2359 | 0.070 |
Why?
|
| Male | 14 | 2021 | 123000 | 0.070 |
Why?
|
| Gene Library | 2 | 2006 | 294 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2013 | 992 | 0.070 |
Why?
|
| Clone Cells | 2 | 2006 | 555 | 0.070 |
Why?
|
| Caspase 8 | 1 | 2006 | 145 | 0.070 |
Why?
|
| RNA, Neoplasm | 3 | 1994 | 771 | 0.070 |
Why?
|
| Risk Factors | 2 | 2016 | 17523 | 0.070 |
Why?
|
| Mutation | 6 | 2011 | 15179 | 0.070 |
Why?
|
| Actins | 2 | 2006 | 608 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2007 | 1555 | 0.070 |
Why?
|
| Immunohistochemistry | 3 | 2008 | 7548 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 803 | 0.070 |
Why?
|
| Hydrolysis | 2 | 1999 | 227 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2004 | 4143 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2021 | 5542 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2005 | 64 | 0.070 |
Why?
|
| Gene Silencing | 2 | 2006 | 837 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2008 | 1053 | 0.070 |
Why?
|
| Organ Specificity | 1 | 2007 | 699 | 0.070 |
Why?
|
| Middle Aged | 7 | 2021 | 86204 | 0.070 |
Why?
|
| Introns | 1 | 2006 | 432 | 0.070 |
Why?
|
| DNA, Neoplasm | 2 | 2006 | 1910 | 0.070 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2006 | 518 | 0.060 |
Why?
|
| Mannose-Binding Lectins | 1 | 2005 | 29 | 0.060 |
Why?
|
| Patient Selection | 1 | 2013 | 2055 | 0.060 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 2004 | 136 | 0.060 |
Why?
|
| Methylation | 1 | 2006 | 597 | 0.060 |
Why?
|
| RNA, Catalytic | 1 | 2004 | 37 | 0.060 |
Why?
|
| Heparitin Sulfate | 1 | 2004 | 35 | 0.060 |
Why?
|
| Recombinant Proteins | 3 | 2001 | 2927 | 0.060 |
Why?
|
| Age Factors | 1 | 2014 | 5377 | 0.060 |
Why?
|
| Mosaicism | 1 | 2006 | 272 | 0.060 |
Why?
|
| Alcian Blue | 1 | 2004 | 8 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2013 | 2022 | 0.060 |
Why?
|
| Benzimidazoles | 1 | 2007 | 428 | 0.060 |
Why?
|
| Genes, Synthetic | 1 | 2004 | 26 | 0.060 |
Why?
|
| Incidence | 2 | 2011 | 5673 | 0.060 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2004 | 31 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 4892 | 0.060 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2004 | 106 | 0.060 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2004 | 161 | 0.060 |
Why?
|
| Growth Substances | 1 | 2004 | 300 | 0.060 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2005 | 347 | 0.060 |
Why?
|
| Nuclear Proteins | 2 | 2005 | 3343 | 0.060 |
Why?
|
| Adult | 5 | 2014 | 77950 | 0.060 |
Why?
|
| Epididymis | 1 | 2003 | 68 | 0.060 |
Why?
|
| Enzyme Precursors | 1 | 2003 | 66 | 0.060 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 289 | 0.060 |
Why?
|
| Transcription Factor AP-2 | 2 | 2003 | 79 | 0.060 |
Why?
|
| I-kappa B Kinase | 2 | 2004 | 250 | 0.060 |
Why?
|
| Histone Deacetylase 2 | 1 | 2002 | 35 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2004 | 280 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2007 | 4938 | 0.050 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2002 | 53 | 0.050 |
Why?
|
| Blotting, Southern | 2 | 1992 | 406 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2004 | 997 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2005 | 419 | 0.050 |
Why?
|
| Cross-Linking Reagents | 2 | 1992 | 153 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2013 | 2819 | 0.050 |
Why?
|
| Membrane Glycoproteins | 2 | 2005 | 1073 | 0.050 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2004 | 270 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 741 | 0.050 |
Why?
|
| Cell Separation | 1 | 2004 | 612 | 0.050 |
Why?
|
| Neoplasms | 2 | 2006 | 15193 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2003 | 875 | 0.050 |
Why?
|
| Epithelium | 1 | 2004 | 720 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 15862 | 0.050 |
Why?
|
| STAT1 Transcription Factor | 1 | 2002 | 156 | 0.050 |
Why?
|
| Uterus | 1 | 2006 | 678 | 0.050 |
Why?
|
| G2 Phase | 1 | 2002 | 206 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 1450 | 0.050 |
Why?
|
| Kisspeptins | 1 | 2001 | 15 | 0.050 |
Why?
|
| Radiation, Ionizing | 1 | 2002 | 187 | 0.050 |
Why?
|
| Hydroxamic Acids | 1 | 2004 | 442 | 0.050 |
Why?
|
| Receptors, Androgen | 1 | 2006 | 878 | 0.050 |
Why?
|
| Gene Amplification | 2 | 1994 | 731 | 0.050 |
Why?
|
| Neuregulin-1 | 1 | 2001 | 83 | 0.050 |
Why?
|
| Consensus Sequence | 1 | 2000 | 117 | 0.050 |
Why?
|
| Histone Deacetylases | 1 | 2002 | 365 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2013 | 6869 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2000 | 354 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2005 | 854 | 0.040 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 1999 | 43 | 0.040 |
Why?
|
| Placenta | 1 | 2003 | 516 | 0.040 |
Why?
|
| Mouth Floor | 1 | 1998 | 12 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 1993 | 1618 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 568 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 2508 | 0.040 |
Why?
|
| Sarcoma, Ewing | 1 | 2002 | 406 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2000 | 844 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 1998 | 33 | 0.040 |
Why?
|
| Glycoside Hydrolases | 1 | 1998 | 37 | 0.040 |
Why?
|
| Genome, Human | 1 | 2006 | 1869 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2011 | 2947 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 1999 | 1489 | 0.040 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2003 | 600 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2002 | 2074 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2014 | 29902 | 0.040 |
Why?
|
| Female | 9 | 2021 | 141928 | 0.040 |
Why?
|
| Oncogene Proteins v-fos | 1 | 1996 | 3 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2001 | 1064 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 1998 | 334 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2006 | 5710 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1996 | 123 | 0.040 |
Why?
|
| Isoflavones | 1 | 1996 | 72 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2021 | 708 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1997 | 248 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1995 | 264 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1996 | 261 | 0.030 |
Why?
|
| Aged | 4 | 2021 | 70117 | 0.030 |
Why?
|
| Young Adult | 1 | 2014 | 21445 | 0.030 |
Why?
|
| Codon | 1 | 1995 | 241 | 0.030 |
Why?
|
| Liver Neoplasms | 2 | 2010 | 4557 | 0.030 |
Why?
|
| Lung | 1 | 2006 | 3151 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 1995 | 355 | 0.030 |
Why?
|
| Trypsin | 1 | 1995 | 140 | 0.030 |
Why?
|
| Solubility | 1 | 1995 | 242 | 0.030 |
Why?
|
| Phorbol Esters | 1 | 1994 | 39 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1996 | 483 | 0.030 |
Why?
|
| DNA | 3 | 2005 | 2693 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2001 | 3203 | 0.030 |
Why?
|
| Glioblastoma | 2 | 1997 | 1797 | 0.030 |
Why?
|
| Chemotaxis | 1 | 1995 | 138 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 1998 | 750 | 0.030 |
Why?
|
| Antigens, CD | 1 | 1999 | 1385 | 0.030 |
Why?
|
| Polycyclic Compounds | 1 | 1993 | 9 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 1993 | 19 | 0.030 |
Why?
|
| Genes | 1 | 1994 | 491 | 0.030 |
Why?
|
| Cell Adhesion | 3 | 2004 | 1008 | 0.030 |
Why?
|
| Diagnostic Techniques, Radioisotope | 1 | 1992 | 2 | 0.030 |
Why?
|
| Epitopes | 1 | 1995 | 685 | 0.030 |
Why?
|
| Brain Neoplasms | 2 | 2002 | 4849 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2003 | 191 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2001 | 1823 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 1999 | 1506 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1998 | 1331 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 1993 | 396 | 0.030 |
Why?
|
| Aerospace Medicine | 1 | 2011 | 51 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 1998 | 1491 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2021 | 9180 | 0.020 |
Why?
|
| Breast Neoplasms | 3 | 2004 | 15694 | 0.020 |
Why?
|
| Protein Stability | 1 | 2010 | 370 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 3 | 2005 | 4367 | 0.020 |
Why?
|
| Suspensions | 1 | 1988 | 17 | 0.020 |
Why?
|
| Sepharose | 1 | 1988 | 32 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 9244 | 0.020 |
Why?
|
| Transferrin | 1 | 1988 | 78 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2010 | 344 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2011 | 1546 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2005 | 5061 | 0.020 |
Why?
|
| Mice, Inbred AKR | 1 | 1987 | 51 | 0.020 |
Why?
|
| Gene Deletion | 2 | 2004 | 1442 | 0.020 |
Why?
|
| Culture Media | 1 | 1988 | 319 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2005 | 2314 | 0.020 |
Why?
|
| RANK Ligand | 1 | 2007 | 119 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 1988 | 423 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 1995 | 4971 | 0.020 |
Why?
|
| Osteosarcoma | 1 | 1993 | 929 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2006 | 162 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2006 | 392 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2007 | 503 | 0.020 |
Why?
|
| Amiloride | 1 | 2005 | 47 | 0.020 |
Why?
|
| Peptide Nucleic Acids | 1 | 2005 | 3 | 0.020 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1997 | 2326 | 0.020 |
Why?
|
| Luciferases, Firefly | 1 | 2005 | 39 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2004 | 4078 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 342 | 0.020 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2005 | 142 | 0.020 |
Why?
|
| Paxillin | 1 | 2004 | 30 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2006 | 256 | 0.020 |
Why?
|
| Focal Adhesions | 1 | 2004 | 45 | 0.020 |
Why?
|
| Lithium Chloride | 1 | 2004 | 28 | 0.020 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2005 | 196 | 0.020 |
Why?
|
| Cell Size | 1 | 2004 | 136 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2021 | 37905 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2004 | 163 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1997 | 3022 | 0.010 |
Why?
|
| Transcription Factor RelA | 1 | 2004 | 184 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 215 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2004 | 267 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2004 | 461 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1995 | 2341 | 0.010 |
Why?
|
| Gelatin | 1 | 2002 | 49 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 571 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2005 | 630 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 492 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2004 | 435 | 0.010 |
Why?
|
| DNA Helicases | 1 | 2004 | 434 | 0.010 |
Why?
|
| Insulin | 1 | 1988 | 1454 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2004 | 576 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 483 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2004 | 558 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2004 | 614 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2011 | 6100 | 0.010 |
Why?
|
| Spheroids, Cellular | 1 | 2002 | 222 | 0.010 |
Why?
|
| Heterozygote | 1 | 2004 | 1020 | 0.010 |
Why?
|
| Dichlororibofuranosylbenzimidazole | 1 | 2001 | 12 | 0.010 |
Why?
|
| Macrophages | 1 | 2007 | 1304 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2001 | 82 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 2002 | 271 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2001 | 211 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2004 | 657 | 0.010 |
Why?
|
| Melanoma | 1 | 1998 | 5317 | 0.010 |
Why?
|
| RNA Stability | 1 | 2001 | 125 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2002 | 663 | 0.010 |
Why?
|
| Neoplasm Staging | 3 | 2001 | 13658 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 32848 | 0.010 |
Why?
|
| Basigin | 1 | 1999 | 20 | 0.010 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 1999 | 34 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 1995 | 4638 | 0.010 |
Why?
|
| Neck Muscles | 1 | 1998 | 38 | 0.010 |
Why?
|
| Tongue | 1 | 1998 | 77 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1999 | 254 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2005 | 1547 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1998 | 255 | 0.010 |
Why?
|
| Gelatinases | 1 | 1997 | 52 | 0.010 |
Why?
|
| Mandible | 1 | 1998 | 188 | 0.010 |
Why?
|
| Random Allocation | 1 | 1998 | 703 | 0.010 |
Why?
|
| Genetic Therapy | 1 | 2005 | 1616 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 1999 | 246 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2004 | 2054 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1999 | 875 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 1997 | 626 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2004 | 4804 | 0.010 |
Why?
|
| Phenotype | 1 | 1987 | 6295 | 0.010 |
Why?
|
| Heparin | 1 | 1998 | 360 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1997 | 11538 | 0.010 |
Why?
|
| Smoking | 1 | 2004 | 2440 | 0.010 |
Why?
|
| Aminocaproic Acid | 1 | 1994 | 17 | 0.010 |
Why?
|
| Liver Diseases | 1 | 1999 | 574 | 0.010 |
Why?
|
| Fibrinolysin | 1 | 1993 | 33 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2004 | 6942 | 0.010 |
Why?
|
| Biocompatible Materials | 1 | 1994 | 202 | 0.010 |
Why?
|
| Hyaluronic Acid | 1 | 1994 | 168 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2005 | 2027 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1991 | 54 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1993 | 889 | 0.010 |
Why?
|
| Inflammation | 1 | 1999 | 2522 | 0.010 |
Why?
|
| Rats | 1 | 1998 | 6086 | 0.010 |
Why?
|
| Survival Rate | 1 | 2002 | 12221 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1998 | 2967 | 0.000 |
Why?
|
| Pregnancy | 1 | 1999 | 7573 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1998 | 7222 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1998 | 12873 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1998 | 14889 | 0.000 |
Why?
|
| Prognosis | 1 | 1999 | 21713 | 0.000 |
Why?
|